| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718713A Colourless transparent health care wine for aged and middle aged person and its preparation method |
| 01/11/2006 | CN1718585A Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 01/11/2006 | CN1718577A Medicinal composition containing alkyl acyl ramosqiong and its application |
| 01/11/2006 | CN1718239A Oral adhering piece for treating oral exulceratio, and its prepn. method |
| 01/11/2006 | CN1718232A Compound traditional Chinese medicine for treating acute gastroenteritis and anti-influenzavirus, and its prepn. method |
| 01/11/2006 | CN1718225A Compound traditional Chinese medicine for treating hepatic lesion, and its prepn. method |
| 01/11/2006 | CN1718222A Anti-inflammation buccal tablet |
| 01/11/2006 | CN1718220A method for discerning tablets of tonifying stomach and promoting digestion |
| 01/11/2006 | CN1718219A Method for preparing traditional Chinese medicine capsule for treating weakness of spleen and stomach, and its quality control method |
| 01/11/2006 | CN1718206A Traditional Chinese medicine composition for treating asthenic disease, prepn. method and quality-standard thereof |
| 01/11/2006 | CN1718201A Medicine used for tonifying-kidney strengthening-yang and replenishing-qi to invigorate the spleen, and its prepn. method |
| 01/11/2006 | CN1718186A Anethol trithione dripping pills, and its preparing method |
| 01/11/2006 | CN1718185A Long-acting anethol trithione prepn. and its prepn. method |
| 01/11/2006 | CN1236043C Supplemental strengthening wine and preparing process thereof |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235636C Chinese medicine capsule treating gastropathy |
| 01/11/2006 | CN1235634C Chinese medicine powder for treating gallstones and preparation method thereof |
| 01/11/2006 | CN1235629C Traditional Chinese medicine composition for treating choleithiasis |
| 01/11/2006 | CN1235628C Lithagogue decoction |
| 01/11/2006 | CN1235616C Composition for preventing and treating pig's epidemic diarrhea |
| 01/11/2006 | CN1235613C Medicine for promoting gastrointestinal function and its prepn process |
| 01/11/2006 | CN1235610C Chinese medicinal composition for treating acute pharyngitis and gingivitis and preparing method thereof |
| 01/11/2006 | CN1235603C Dry rhizopus bacteria suspension, its prepn process and use |
| 01/11/2006 | CN1235601C Extractive of ocean star worm, its preparing method and application |
| 01/11/2006 | CN1235598C Process for preparing buccal lozenge contg. compound sede-iodine |
| 01/11/2006 | CN1235592C Glycyrrhizin triple composition nano micro particle and its preparing method |
| 01/11/2006 | CN1235591C Composition for preventing and treating yellow dysentery of piglet |
| 01/11/2006 | CN1235584C Sustained release tablet of matrine and its preparing method |
| 01/11/2006 | CN1235578C Fumaric acid microtablets |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984650 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984376 Methods of inhibiting dental erosion/discoloration using a beverage composition comprising a long chain polyphosphate |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2214033C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006002375A2 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004101 Inhibitor for liver cancer onset and progress |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004015 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003932 Method for promoting neovascularization |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | US20060003026 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | CA2571584A1 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 01/05/2006 | CA2571569A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/04/2006 | EP1612273A1 Novel physiologically active substances pf1270a, b and c |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612225A1 Modified acacia and use thereof |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1611901A1 Preventive or remedy for teeth grinding |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1610794A1 A method of treating liver disease |
| 01/04/2006 | EP1610770A1 Use of an ibat inhibitor for the treatment of prophylaxis of constipation |
| 01/04/2006 | EP1472514A4 Method of preparing delta-9 tetrahydrocannabinol |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1237553B1 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1077728B1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 01/04/2006 | CN1717243A Papaya puree and the use of the same |